Literature DB >> 9876295

Renal dysfunction in patients with sickle cell anemia or sickle cell trait.

R Sesso1, M A Almeida, M S Figueiredo, J O Bordin.   

Abstract

Patients with sickle cell anemia (Hb SS) or sickle cell trait (Hb AS) may present several types of renal dysfunction; however, comparison of the prevalence of these abnormalities between these two groups and correlation with the duration of disease in a large number of patients have not been thoroughly investigated. In a cross-sectional study using immunoenzymometric assays to measure tubular proteinuria, microalbuminuria, measurement of creatinine clearance, urinary osmolality and analysis of urine sediment, we evaluated glomerular and tubular renal function in 106 adults and children with Hb SS (N = 66) or Hb AS (N = 40) with no renal failure (glomerular filtration rate (GFR) > 85 ml/min). The percentage of individuals with microalbuminuria was higher among Hb SS than among Hb AS patients (30 vs 8%, P < 0.0001). The prevalence of microhematuria was similar in both groups (26 vs 30%, respectively). Increased urinary levels of retinol-binding protein or beta 2-microglobulin were detected in only 3 Hb SS and 2 Hb AS patients. Urinary osmolality was reduced in patients with Hb SS or with Hb AS; however, it was particularly evident in Hb SS patients older than 15 years (median = 393 mOsm/kg, range = 366-469) compared with Hb AS patients (median = 541 mOsm/kg, range = 406-722). Thus, in addition to the frequently reported early reduction of urinary osmolality and increased GFR, nondysmorphic hematuria was found in 26 and 30% of patients with Hb SS or Hb AS, respectively. Microalbuminuria is an important marker of glomerular injury in patients with Hb SS and may also be demonstrated in some Hb AS individuals. Significant proximal tubular dysfunction is not a common feature in Hb SS and Hb AS population at this stage of the disease (i.e., GFR > 85 ml/min).

Entities:  

Mesh:

Year:  1998        PMID: 9876295     DOI: 10.1590/s0100-879x1998001000004

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  20 in total

1.  High prevalence of sickle cell trait in African Americans with ESRD.

Authors:  Vimal K Derebail; Patrick H Nachman; Nigel S Key; Heather Ansede; Ronald J Falk; Abhijit V Kshirsagar
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

2.  Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose.

Authors:  Vimal K Derebail; Eduardo K Lacson; Abhijit V Kshirsagar; Nigel S Key; Susan L Hogan; Raymond M Hakim; Ann Mooney; Chinu M Jani; Curtis Johnson; Yichun Hu; Ronald J Falk; J Michael Lazarus
Journal:  J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 10.121

3.  Congolese children with sickle cell trait may exhibit glomerular hyperfiltration: A case control study.

Authors:  Michel Ntetani Aloni; René Makwala Ngiyulu; Célestin Ndosimao Nsibu; Pépé Mfutu Ekulu; Jean Robert Makulo; Jean-Lambert Gini-Ehungu; Nazaire Mangani Nseka; François Bompeka Lepira
Journal:  J Clin Lab Anal       Date:  2017-01-19       Impact factor: 2.352

Review 4.  Sickle cell nephropathy: challenging the conventional wisdom.

Authors:  Amy M Becker
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

Review 5.  Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory.

Authors:  Nigel S Key; Philippe Connes; Vimal K Derebail
Journal:  Br J Haematol       Date:  2015-03-07       Impact factor: 6.998

6.  Sickle cell trait and renal disease among African American U.S. Army soldiers.

Authors:  Jiaqi Hu; D Alan Nelson; Patricia A Deuster; Eric S Marks; Francis G O'Connor; Lianne M Kurina
Journal:  Br J Haematol       Date:  2019-03-11       Impact factor: 6.998

Review 7.  Sickle-cell trait: novel clinical significance.

Authors:  Nigel S Key; Vimal K Derebail
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

8.  Comparison of renal function markers in Kuwaiti patients with sickle cell disease.

Authors:  R Marouf; O Mojiminiyi; N Abdella; M Kortom; H Al Wazzan
Journal:  J Clin Pathol       Date:  2006-04       Impact factor: 3.411

9.  Biochemical indicator of sickle cell disease: preliminary report from India.

Authors:  S Pandey; A Sharma; S Dahia; V Shah; V Sharma; R M Mishra; Sw Pandey; R Saxena
Journal:  Indian J Clin Biochem       Date:  2011-09-25

10.  The increasing prevalence of childhood sickle-cell disease in Ireland.

Authors:  C McMahon; C O Callaghan; D O'Brien; O P Smith
Journal:  Ir J Med Sci       Date:  2001 Jul-Sep       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.